Seguir
Sanjay Mathew
Sanjay Mathew
Dirección de correo verificada de bcm.edu
Título
Citado por
Citado por
Año
Antidepressant efficacy of ketamine in treatment-resistant major depression: a two-site randomized controlled trial
JW Murrough, DV Iosifescu, LC Chang, RK Al Jurdi, CE Green, AM Perez, ...
American Journal of Psychiatry 170 (10), 1134-1142, 2013
12722013
Rapid and longer-term antidepressant effects of repeated ketamine infusions in treatment-resistant major depression
JW Murrough, AM Perez, S Pillemer, J Stern, MK Parides, M aan het Rot, ...
Biological psychiatry 74 (4), 250-256, 2013
7612013
Effects of intravenous ketamine on explicit and implicit measures of suicidality in treatment-resistant depression
RB Price, MK Nock, DS Charney, SJ Mathew
Biological psychiatry 66 (5), 522-526, 2009
7172009
The effect of a single dose of intravenous ketamine on suicidal ideation: a systematic review and individual participant data meta-analysis
ST Wilkinson, ED Ballard, MH Bloch, SJ Mathew, JW Murrough, A Feder, ...
American journal of psychiatry 175 (2), 150-158, 2018
5802018
Safety and efficacy of repeated-dose intravenous ketamine for treatment-resistant depression
M Aan Het Rot, KA Collins, JW Murrough, AM Perez, DL Reich, ...
Biological psychiatry 67 (2), 139-145, 2010
5612010
Neurobiological mechanisms in major depressive disorder
M aan het Rot, SJ Mathew, DS Charney
Cmaj 180 (3), 305-313, 2009
4522009
A consensus statement on the use of ketamine in the treatment of mood disorders
G Sanacora, MA Frye, W McDonald, SJ Mathew, MS Turner, ...
JAMA psychiatry 74 (4), 399-405, 2017
4492017
Targeting glutamate signalling in depression: progress and prospects
JW Murrough, CG Abdallah, SJ Mathew
Nature Reviews Drug Discovery 16 (7), 472-486, 2017
3952017
Ketamine for depression: where do we go from here?
M Aan Het Rot, CA Zarate Jr, DS Charney, SJ Mathew
Biological psychiatry 72 (7), 537-547, 2012
3712012
Effects of ketamine on explicit and implicit suicidal cognition: A randomized controlled trial in treatment‐resistant depression
RB Price, DV Iosifescu, JW Murrough, LC Chang, RK Al Jurdi, SZ Iqbal, ...
Depression and anxiety 31 (4), 335-343, 2014
3602014
Double-blind, placebo-controlled, dose-ranging trial of intravenous ketamine as adjunctive therapy in treatment-resistant depression (TRD)
M Fava, MP Freeman, M Flynn, H Judge, BB Hoeppner, C Cusin, ...
Molecular psychiatry 25 (7), 1592-1603, 2020
3182020
Novel drugs and therapeutic targets for severe mood disorders
SJ Mathew, HK Manji, DS Charney
Neuropsychopharmacology 33 (9), 2080-2092, 2008
3112008
Amino acid neurotransmitters assessed by proton magnetic resonance spectroscopy: relationship to treatment resistance in major depressive disorder
RB Price, DC Shungu, X Mao, P Nestadt, C Kelly, KA Collins, ...
Biological psychiatry 65 (9), 792-800, 2009
2882009
Ketamine for treatment-resistant unipolar depression: current evidence
SJ Mathew, A Shah, K Lapidus, C Clark, N Jarun, B Ostermeyer, ...
CNS drugs 26, 189-204, 2012
2712012
Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo-controlled continuation trial
SJ Mathew, JW Murrough, M aan het Rot, KA Collins, DL Reich, ...
The The International Journal of Neuropsychopharmacology 13 (1), 71-82, 2010
2622010
Plasma brain derived neurotrophic factor (BDNF) and response to ketamine in treatment-resistant depression
CN Haile, JW Murrough, DV Iosifescu, LC Chang, RK Al Jurdi, A Foulkes, ...
International Journal of Neuropsychopharmacology 17 (2), 331-336, 2014
2572014
Neurobiology of anxiety disorders and implications for treatment
A Garakani, S Mathew, DS Charney
Mount Sinai Journal of Medicine 73 (7), 941-949, 2006
2522006
aan het Rot M, Collins KA, Reich DL, Charney DS. Riluzole for relapse prevention following intravenous ketamine in treatment-resistant depression: a pilot randomized, placebo …
SJ Mathew, JW Murrough
Int J Neuropsychopharmacol 13 (1), 71-82, 2010
2422010
Neurobiological mechanisms of social anxiety disorder
SJ Mathew, JD Coplan, JM Gorman
American journal of psychiatry 158 (10), 1558-1567, 2001
2422001
Molecular targets in the treatment of anxiety
JM Kent, SJ Mathew, JM Gorman
Biological psychiatry 52 (10), 1008-1030, 2002
2352002
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20